2 to 3 in every 50 babies (4–6%) who develop GBS disease die.1
About 1 in 4 pregnant women carries GBS bacteria in their body.2
Automated Extraction & PCR Setup
CFX96™ Real-time PCR System (Bio-Rad)
CFX96™ Opus (Bio-Rad)
CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad)
CFX96™ Dx System (Bio-Rad)
- Quick and easy data analysis and interpretation
- Interface specialized for multiplex testing
- Simultaneous detection and identification of 8+ GBS serotypes
- Short TAT (4 hours) from extraction to the final results
- Informative data with individual Ct values for each analyte
Select the assays you are interested in and a Seegene representative will contact you to complete your order.
Group B strep (GBS) disease is often serious and early detection is very important.
Group B Streptococcus (group B strep) or S. agalactiae is a species of bacterium that causes illness in people of all ages. Also known as GBS, this bacterium is a common cause of severe infections in newborns during the first week of life. More recently, experts recognized the increasing impact invasive GBS disease has on adults.
GBS is currently divided into ten serotypes based on type-specific capsular antigens and are designated as Ia, Ib, II, III, IV, V, VI, VII, VIII, and IX. Real-time PCR is one of several methods that can be used to rapidly detect and distinguish different GSB serotypes.
Novaplex™ GBS Typing Assay* is a qualitative in vitro test for the detection of GBS targets. Novaplex™ GBS Typing Assay is a multiplex real-time PCR assay that permits the simultaneous amplification and detection of target nucleic acids of the GBS inclusive of serotypes – Ia, Ib, II, III, IV, V, VI, Others (VII, VIII, IX).
*Novaplex™ Assays are for Research Use Only. Not for use in Diagnostic Procedures.